Birdwatch Note
2024-04-21 01:59:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Japan has not banned mRNA COVID vaccines, nor has it declared them as a class 1 carcinogen. In fact, Japan’s Ministry of Health, Labour and Welfare recently approved the first Self-Amplifying mRNA vaccine for COVID in adults. https://fullfact.org/health/Japan-not-banned-Covid-vaccine/ https://www.prnewswire.com/news-releases/japans-ministry-of-health-labour-and-welfare-approves-csl-and-arcturus-therapeutics-arct-154-the-first-self-amplifying-mrna-vaccine-approved-for-covid-in-adults-301999193.html https://www.reuters.com/fact-check/japan-is-not-banning-covid-vaccines-contrary-online-claims-2024-03-29/ https://www.reuters.com/article/idUSL1N2UM24J/
Written by 8E0782E7F593AE43DE132F9A686B9623FE5078AF96C0655960B8BBFA4E740320
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1781770285743845662
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1781865426026434702
- noteId - 1781865426026434702
- participantId -
- noteAuthorParticipantId - 8E0782E7F593AE43DE132F9A686B9623FE5078AF96C0655960B8BBFA4E740320 Participant Details
- createdAtMillis - 1713664797680
- tweetId - 1781770285743845662
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Japan has not banned mRNA COVID vaccines, nor has it declared them as a class 1 carcinogen. In fact, Japan’s Ministry of Health, Labour and Welfare recently approved the first Self-Amplifying mRNA vaccine for COVID in adults. https://fullfact.org/health/Japan-not-banned-Covid-vaccine/ https://www.prnewswire.com/news-releases/japans-ministry-of-health-labour-and-welfare-approves-csl-and-arcturus-therapeutics-arct-154-the-first-self-amplifying-mrna-vaccine-approved-for-covid-in-adults-301999193.html https://www.reuters.com/fact-check/japan-is-not-banning-covid-vaccines-contrary-online-claims-2024-03-29/ https://www.reuters.com/article/idUSL1N2UM24J/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-21 01:59:57 UTC (1713664797680) |
2024-04-21 08:23:18 UTC (1713687798353) |
CURRENTLY_RATED_HELPFUL | 2024-04-21 08:23:18 UTC (1713687798353) |
CURRENTLY_RATED_HELPFUL | 2024-04-21 08:23:18 UTC (1713687798353) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-20 23:51:06 -0500 | Rating Details | |
| 2024-04-20 23:43:34 -0500 | Rating Details | |
| 2024-04-20 22:58:51 -0500 | Rating Details | |
| 2024-04-20 22:56:32 -0500 | Rating Details | |
| 2024-04-20 22:37:16 -0500 | Rating Details | |
| 2024-04-20 22:13:13 -0500 | Rating Details | |
| 2024-04-20 22:05:06 -0500 | Rating Details | |
| 2024-04-20 21:30:21 -0500 | Rating Details | |
| 2024-04-20 21:18:01 -0500 | Rating Details | |
| 2024-04-20 21:15:45 -0500 | Rating Details | |
| 2024-04-20 21:10:48 -0500 | Rating Details | |
| 2024-04-20 21:00:54 -0500 | Rating Details | |
| 2024-04-21 13:45:18 -0500 | Rating Details | |
| 2024-04-21 11:34:57 -0500 | Rating Details | |
| 2024-04-21 09:06:03 -0500 | Rating Details | |
| 2024-04-21 06:32:25 -0500 | Rating Details | |
| 2024-04-21 03:46:10 -0500 | Rating Details | |
| 2024-04-21 03:28:02 -0500 | Rating Details | |
| 2024-04-21 01:37:25 -0500 | Rating Details | |
| 2024-04-22 21:34:10 -0500 | Rating Details | |
| 2024-04-25 15:03:33 -0500 | Rating Details | |
| 2024-04-23 03:56:16 -0500 | Rating Details | |
| 2024-04-22 21:34:45 -0500 | Rating Details | |
| 2024-04-22 21:18:41 -0500 | Rating Details | |
| 2024-04-21 06:47:33 -0500 | Rating Details | |
| 2024-04-21 03:01:11 -0500 | Rating Details | |
| 2024-04-21 02:15:19 -0500 | Rating Details | |
| 2024-04-21 01:17:42 -0500 | Rating Details | |
| 2024-04-21 00:38:19 -0500 | Rating Details | |
| 2024-04-20 22:51:51 -0500 | Rating Details | |
| 2024-04-20 22:44:10 -0500 | Rating Details | |
| 2024-04-20 22:40:34 -0500 | Rating Details | |
| 2024-04-20 22:29:23 -0500 | Rating Details | |
| 2024-04-20 22:21:52 -0500 | Rating Details | |
| 2024-04-20 22:10:09 -0500 | Rating Details | |
| 2024-04-20 22:00:58 -0500 | Rating Details | |
| 2024-04-20 21:35:58 -0500 | Rating Details | |
| 2024-04-20 21:19:04 -0500 | Rating Details | |
| 2024-04-20 21:15:34 -0500 | Rating Details | |
| 2024-04-20 21:11:46 -0500 | Rating Details | |
| 2024-04-20 21:10:02 -0500 | Rating Details | |
| 2024-04-22 22:05:47 -0500 | Rating Details | |
| 2024-04-21 03:09:57 -0500 | Rating Details | |
| 2024-04-21 00:46:02 -0500 | Rating Details | |
| 2024-04-21 00:43:58 -0500 | Rating Details | |
| 2024-04-20 23:09:37 -0500 | Rating Details | |
| 2024-04-20 23:07:16 -0500 | Rating Details | |
| 2024-04-20 22:56:51 -0500 | Rating Details | |
| 2024-04-20 22:38:40 -0500 | Rating Details | |
| 2024-04-20 22:25:53 -0500 | Rating Details | |
| 2024-04-20 22:25:24 -0500 | Rating Details | |
| 2024-04-20 22:06:20 -0500 | Rating Details | |
| 2024-04-20 21:43:41 -0500 | Rating Details | |
| 2024-04-20 21:38:15 -0500 | Rating Details | |
| 2024-04-20 21:35:00 -0500 | Rating Details | |
| 2024-04-20 21:30:22 -0500 | Rating Details | |
| 2024-04-20 21:13:43 -0500 | Rating Details | |
| 2024-04-20 21:02:52 -0500 | Rating Details | |
| 2024-04-21 14:15:16 -0500 | Rating Details | |
| 2024-04-21 12:46:04 -0500 | Rating Details | |
| 2024-04-21 07:42:18 -0500 | Rating Details | |
| 2024-04-21 03:36:50 -0500 | Rating Details | |
| 2024-04-21 00:44:51 -0500 | Rating Details | |
| 2024-04-20 22:59:54 -0500 | Rating Details | |
| 2024-04-20 22:08:01 -0500 | Rating Details | |
| 2024-04-20 21:35:40 -0500 | Rating Details | |
| 2024-04-20 21:35:32 -0500 | Rating Details | |
| 2024-04-20 21:26:33 -0500 | Rating Details | |
| 2024-04-20 21:12:27 -0500 | Rating Details | |
| 2024-04-20 21:03:58 -0500 | Rating Details | |
| 2024-04-20 21:00:48 -0500 | Rating Details | |
| 2024-04-22 21:28:57 -0500 | Rating Details |